Valeritas’ V-Go® Wearable Insulin Delivery Device Demonstrates Economic Advantages Compared to Multiple Daily Injection Therapy for Insulin Dependent Type 2 Diabetes Population July 8, 2019 - NASDAQ Companies 0 » View More News for July 08, 2019
